Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A new lotion with halobetasol and tazarotene successfully treats acne keloidalis nuchae.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

The combination of minoxidil and finasteride is more effective for hair growth than minoxidil alone.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Adding licorice gel to laser treatment is more effective for reducing facial hair than laser alone.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.